Open clinical trials: LION surgical trial in advanced ovarian cancer Treosulfan chemotherapy in metastatic ovarian cancer AGO-Zervix-1 chemotherapy in recurrent or metastatic cervical cancer CBKM120C2201 phase II study in metastatic endometrial cancer - first line Vulva SLN surgical therapy in vulvar cancer IRESSA-follow-up endometrial cancer Ovar-9 ovarian cancer – first line LRH-Studie nerve sparing laparoscopic radical hysterectomie in cervical cancer Staging-Studie laparoscopy in early ovarian cancer FISH translocational trial CIN lesions QUIPS New pain management in laparoscopic surgery - prospective trial in cooperation with the department of anesthesiology Closed clinical trials (follow-up phase): HECTOR chemotherapy in recurrent ovarian cancer Ovar 11 chemotherapy in ovarian cancer MIMOSA antidodies for treatment in advanced ovarian cancer Gynecological Cancer Centre Gynecological Cancer Centre Jena Jena 18.05.2011 Cooperation partners Patien t number Firs t onse t Recurrence s Number of interventi ons Primar y Recurrence s 2009 197 161 36 192 160 32 2010 171 111 60 153 110 43 Certified gynecological cancer centre Certified by ESGO since 28.10.2007 Certified by DKG since 02.06.2010 Number of patients with gynecological malignancies Special competences Clinical studies Primary Recurrence s Ovary 60 11 Cervix 42 12 Endometriu m 42 6 Vulva 10 5 Others 7 2 • Full range of gyneco-oncological surgery • Sentinel lymphnode biopsy (vulva, cervix) • Nerve and/or organ sparing laparoscopic radical surgery • Multivisceral surgery • Cryopreservation • Plastic reconstructive surgery • Radio- and chemotherapy • Hormone- and immunotherapy • Psychological and pastoral care • Naturopathic treatment and nutrition counseling • Second opinion • Tumorboard weekly, 5 disciplines present teleboard for external partners • Interdisciplinary prevention (gynecologic, genetic, psychological) Outreach • Cooperation with specialised gyneco-oncological medical practices in and around Jena • Arrangements with regional hospitals (Stollberg, Suhl, Heiligenstadt, Eisenach, Arnstadt, Schmalkald • Cooperation with medical oncologists Surgery hours • Gynecological and radiotherapeutical follow-up • Medical psychology • Cervical and vulval dysplasia • Reproductive medicine • Interdisciplinary gynecologic-internistic oncology Cancer entities 2009 Director: Ingo B. Runnebaum, MD, MBA Coordinator: Oumar Camara, MD www.frauenheilkunde.uniklinikum-jena.de/Gynaekologisches_Krebszentrum.de